INTRODUCTION AND OBJECTIVES: Partial nephrectomy (PN) is considered a strong (imperative/relative) indication for patients with stage 3 chronic kidney disease [(CKD), estimated glomerular filtration rate (eGFR)<60 ml/min/1.73m2] and is considered elective for patients with higher GFR. Change in GFR (DGFR) is less for PN compared to radical nephrectomy (RN), and patients with stage 2 CKD (eGFR 60-89) may be at increased risk for postoperative renal decline to thresholds of increased risk. We compared renal function and survival outcomes in patients with baseline stage 2 CKD who underwent PN or RN.
METHODS: International multicenter retrospective analysis of patients with baseline stage 2 CKD who underwent PN or RN from 1987-2015. Demographics, disease characteristics, survival and renal function outcomes were recorded. Patients were stratified into baseline Stage 2a CKD (GFR 75-89) and Stage 2b CKD (GFR 60-74.9) for analysis. Primary outcome was DGFR at last follow up. Secondary outcomes included occurrence of GFR<45, a risk factor for poor survival outcomes, and overall survival (OS). Cox proportional hazard regression, Kaplan Meier analysis, and multivariable (MV) regression for risk factors associated with outcomes was performed.
RESULTS: 1460 patients were analyzed (mean age 61.9 years, median follow up 46 months). 49.3% underwent PN/50.7% underwent RN, and 49.5% were Stage 2a CKD (n¼723) while 50.5% were Stage 2b CKD (n¼737). Mean DGFR was greater for RN than PN overall (-12.5 vs. -6.5, p<0.001), in stage 2a CKD (-12.9 vs. -10.0, p<0.001), and stage 2b CKD (-11.9 vs. -2.9, p<0.001). Cox proportional hazard regression for GFR<45 noted negative effect for RN overall (HR 1.78, p<0.001), in Stage 2a CKD (HR 1.88, p¼0.019), and in Stage 2b CKD (HR 1.74, p¼0.002). On MV regression for GFR<45, Stage 2b CKD (OR 1.70, p<0.001) and RN (OR 1.47, p¼0.028) were independent risk factors. MV regression for OS was worse for RN overall (OR 2.93, p<0.001), in Stage 2a CKD (OR 3.12, p<0.001), and in 2b CKD (OR 2.77, p<0.001).
CONCLUSIONS: Patients with baseline Stage 2 CKD undergoing RN are at increased risk of GFR decline, including the threshold of GFR<45, and worsened OS. For patients with Stage 2 CKD, PN may be considered a relative indication and should be prioritized when appropriate. cell carcinoma, treatment of larger renal tumors is controversial. We evaluated the oncological outcomes and perioperative complications after radical and partial nephrectomy for renal cell carcinoma 4 cm.
Source of
METHODS: We retrospectively analyzed the data of 2,373 patients surgically treated for non-metastatic RCC with clinical T1b or T2 ( 4 cm). The propensity scores for surgery type were calculated and the partial group was matched to the radical group in a 1:3 ratio. The oncological outcomes were compared using Kaplan-Meier analysis and multivariate Cox regression models were utilized to identify the independent predictors of progression-free, cancer-specific, and overall survival.
RESULTS: All differences in preoperative clinical characteristics disappeared after matching. There were no significant differences in progression-free, cancer-specific, or overall survival between the partial and radical groups in the matched cohort. The patients 0 age, tumor size, cellular grade, and pathologic stage were independent predictors for all three survival outcomes. However, early complications (< 30 days postoperative) were significantly more common in the partial group (p < 0.001). In a subgroup analysis of the patients with clinical T2 stage, there were no significant differences in all three survival outcomes.
CONCLUSIONS: The partial and radical nephrectomy groups had equivalent oncological outcomes. Although the early complication rate was significantly higher after partial nephrectomy, it should be considered as a valuable treatment option even in patients with clinical T1b or higher renal cell carcinoma. INTRODUCTION AND OBJECTIVES: The last years have been marked by a growth in the use of partial nephrectomy (PN) for complex renal masses. This has led to an overall increase in the number of tumors found to have adverse pathological features. The aim of this study was to identify patterns and predictors of recurrence in patients with clinically localized renal cell carcinoma managed with PN.
METHODS: Retrospective study of 830 consecutive cases of PN done between 2007 and 2015 at a single institution. Patient demographics, and pathological characteristics were correlated with recurrence patterns (overall, local and distant) and overall survival (OS) using Kaplan-Meier and cox regression analyses. Differences in the recurrence patterns were evaluated. RESULTS: Median age was 61 years, and median tumor size was 3.1 cm. Overall, 11.6% of tumors were pT3 stage, 39.3% were high grade, 2.9% had lymphovascular invasion, and 7.1% had positive Vol. 197, No. 4S, Supplement, Monday, May 15, 2017 THE JOURNAL OF UROLOGY â e955
